Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Recent Patents on CNS Drug Discovery | journal | 0.672 Q2 | 35 | 17 | 64 | 2366 | 149 | 64 | 2.34 | 139.18 | |
2 | Current Molecular Pharmacology | journal | 1.689 Q1 | 46 | 18 | 64 | 2266 | 315 | 64 | 5.34 | 125.89 | |
3 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.997 Q1 | 48 | 33 | 70 | 4134 | 212 | 70 | 3.40 | 125.27 | |
4 | Current Medicinal Chemistry | journal | 1.699 Q1 | 192 | 430 | 828 | 53487 | 4690 | 823 | 5.48 | 124.39 | |
5 | Recent Advances in Drug Delivery and Formulation | journal | 38 | 18 | 59 | 2216 | 175 | 59 | 2.73 | 123.11 | ||
6 | Current Gene Therapy | journal | 1.347 Q1 | 78 | 50 | 132 | 6077 | 671 | 123 | 3.90 | 121.54 | |
7 | Current Pharmaceutical Design | journal | 1.414 Q1 | 176 | 405 | 1128 | 48213 | 4861 | 1016 | 4.20 | 119.04 | |
8 | Current Drug Targets | journal | 1.461 Q1 | 112 | 193 | 419 | 21891 | 1597 | 379 | 3.71 | 113.42 | |
9 | CNS and Neurological Disorders - Drug Targets | journal | 1.468 Q1 | 93 | 99 | 188 | 10725 | 777 | 168 | 4.07 | 108.33 | |
10 | Current Topics in Medicinal Chemistry | journal | 1.351 Q1 | 127 | 229 | 445 | 24674 | 1901 | 377 | 3.84 | 107.75 | |
11 | Current Vascular Pharmacology | journal | 0.944 Q2 | 67 | 74 | 182 | 7940 | 578 | 169 | 3.20 | 107.30 | |
12 | Infectious Disorders - Drug Targets | journal | 0.778 Q2 | 59 | 48 | 131 | 4761 | 340 | 115 | 2.68 | 99.19 | |
13 | Current Cancer Drug Targets | journal | 2.137 Q1 | 99 | 94 | 232 | 8928 | 1117 | 220 | 4.78 | 94.98 | |
14 | Mini-Reviews in Medicinal Chemistry | journal | 0.855 Q2 | 101 | 108 | 395 | 10227 | 1175 | 393 | 2.84 | 94.69 | |
15 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.179 Q3 | 26 | 36 | 111 | 3401 | 43 | 101 | 0.52 | 94.47 | |
16 | Current Pharmacogenomics and Personalized Medicine | journal | 0.291 Q3 | 20 | 30 | 85 | 2789 | 112 | 75 | 1.61 | 92.97 | |
17 | Recent Advances in Anti-Infective Drug Discovery | journal | 35 | 23 | 64 | 2121 | 116 | 64 | 1.86 | 92.22 | ||
18 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.961 Q2 | 42 | 28 | 85 | 2577 | 252 | 84 | 1.98 | 92.04 | |
19 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.126 Q4 | 16 | 33 | 93 | 3010 | 24 | 85 | 0.22 | 91.21 | |
20 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.341 Q1 | 103 | 114 | 262 | 10207 | 948 | 234 | 3.15 | 89.54 | |
21 | Current Drug Therapy | journal | 0.197 Q2 | 19 | 33 | 84 | 2889 | 58 | 81 | 0.59 | 87.55 | |
22 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.140 Q4 | 28 | 25 | 75 | 2156 | 23 | 75 | 0.28 | 86.24 | |
23 | Current Computer-Aided Drug Design | journal | 0.531 Q2 | 31 | 32 | 74 | 2728 | 163 | 70 | 1.91 | 85.25 | |
24 | Reviews on Recent Clinical Trials | journal | 0.718 Q2 | 34 | 30 | 75 | 2410 | 168 | 74 | 2.29 | 80.33 | |
25 | Current Enzyme Inhibition | journal | 0.183 Q4 | 18 | 25 | 63 | 2002 | 28 | 61 | 0.49 | 80.08 | |
26 | Current Neuropharmacology | journal | 1.309 Q1 | 93 | 94 | 102 | 7032 | 445 | 97 | 3.51 | 74.81 | |
27 | Current Drug Discovery Technologies | journal | 0.740 Q2 | 46 | 38 | 95 | 2659 | 275 | 90 | 2.98 | 69.97 | |
28 | Current Radiopharmaceuticals | journal | 0.226 Q3 | 30 | 40 | 55 | 2644 | 35 | 50 | 0.64 | 66.10 | |
29 | Current Drug Delivery | journal | 0.599 Q1 | 68 | 68 | 160 | 4369 | 346 | 159 | 1.92 | 64.25 | |
30 | Current Reviews in Clinical and Experimental Pharmacology | journal | 45 | 38 | 84 | 2420 | 194 | 83 | 2.33 | 63.68 | ||
31 | Current Bioactive Compounds | journal | 0.696 Q1 | 29 | 30 | 75 | 1859 | 123 | 66 | 1.72 | 61.97 | |
32 | Open Medicinal Chemistry Journal | journal | 0.921 Q1 | 21 | 13 | 7 | 776 | 25 | 6 | 3.57 | 59.69 | |
33 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.497 Q2 | 44 | 18 | 97 | 1059 | 156 | 93 | 1.22 | 58.83 | |
34 | Combinatorial Chemistry and High Throughput Screening | journal | 0.645 Q2 | 68 | 93 | 284 | 4945 | 645 | 256 | 2.00 | 53.17 | |
35 | Current Nanoscience | journal | 0.582 Q2 | 51 | 135 | 212 | 6698 | 464 | 212 | 1.94 | 49.61 | |
36 | Medicinal Chemistry | journal | 0.370 Q3 | 48 | 80 | 194 | 3647 | 282 | 194 | 1.50 | 45.59 | |
37 | Current Drug Safety | journal | 0.526 Q2 | 39 | 57 | 117 | 2359 | 248 | 107 | 2.05 | 41.39 | |
38 | Current Pharmaceutical Analysis | journal | 0.417 Q2 | 26 | 37 | 86 | 1517 | 111 | 85 | 1.29 | 41.00 | |
39 | Drug Metabolism Letters | journal | 0.395 Q2 | 31 | 37 | 123 | 1126 | 151 | 121 | 1.05 | 30.43 | |
40 | Letters in Drug Design and Discovery | journal | 0.285 Q2 | 36 | 133 | 298 | 3677 | 273 | 298 | 0.94 | 27.65 | |
41 | Anti-Infective Agents | journal | 0.364 Q3 | 25 | 0 | 68 | 0 | 71 | 65 | 0.77 | 0.00 | |
42 | Current Clinical Pharmacology | journal | 0.752 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
43 | Frontiers in Drug Design and Discovery | book series | 0.134 Q3 | 9 | 0 | 18 | 0 | 8 | 17 | 0.44 | 0.00 | |
44 | Open Drug Discovery Journal | journal | 0.268 Q3 | 10 | 0 | 26 | 0 | 11 | 23 | 0.42 | 0.00 | |
45 | Recent Patents on Drug Delivery and Formulation | journal | 0.745 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
46 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.456 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®